Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Citation
Taylor-Rowan , M , Kraia , O , Kolliopoulou , C , Cross , A J , Stewart , C , Myint , P K , McCleery , J & Quinn , T J 2022 , ' Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. ' , Cochrane Database of Systematic Reviews , vol. 2021 , no. 11 , CD015196 . https://doi.org/10.1002/14651858.CD015196
Rights
This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2021, Issue 11. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol.